Review of the effect of opioid-related side effects on the undertreatment of moderate to severe chronic non-cancer pain: tapentadol, a step toward a solution?

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Current Medical Research and Opinion

• Publication date

  2010-06-15

• Fields of study

  Medicine

• Identifiers
  DOI 10.1185/03007995.2010.483941PMID 20465361
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Management of opioid-induced constipation.

  2016cited by this paper
• Responsible Prescribing of Opioids for the Management of Chronic Pain

  2012cited by this paper
• Opioid‐induced bowel disorders and narcotic bowel syndrome in patients with chronic non‐cancer pain

  2010cited by this paper
• Efficacy and Safety of Tapentadol Extended Release Compared with Oxycodone Controlled Release for the Management of Moderate to Severe Chronic Pain Related to Osteoarthritis of the Knee

  2010cited by this paper
• A randomized, double-blind, placebo-controlled phase 3 study of the relative efficacy and tolerability of tapentadol IR and oxycodone IR for acute pain

  2009cited by this paper
• The prevalence, severity, and impact of opioid-induced bowel dysfunction: results of a US and European Patient Survey (PROBE 1).

  2009cited by this paper
• Management of opioid medications in patients with chronic pain and risk of substance misuse

  2009cited by this paper
• TRPV1 receptor in expression of opioid-induced hyperalgesia.

  2009cited by this paper
• Opioid induced hyperalgesia: clinical implications for the pain practitioner.

  2009cited by this paper
• A randomised controlled trial with prolonged‐release oral oxycodone and naloxone to prevent and reverse opioid‐induced constipation

  2009cited by this paper
• A randomized, double-blind, phase III study comparing multiple doses of tapentadol IR, oxycodone IR, and placebo for postoperative (bunionectomy) pain*

  2009cited by this paper
• What is the Case for Prescribing Long‐Acting Opioids Over Short‐Acting Opioids for Patients with Chronic Pain? A Critical Review

  2009cited by this paper
• Tolerability of tapentadol immediate release in patients with lower back pain or osteoarthritis of the hip or knee over 90 days: a randomized, double-blind study.

  2009cited by this paper
• Efficacy and tolerability of tapentadol immediate release and oxycodone HCl immediate release in patients awaiting primary joint replacement surgery for end-stage joint disease: a 10-day, phase III, randomized, double-blind, active- and placebo-controlled study.

  2009cited by this paper
• Efficacy, safety, and gastrointestinal tolerability of tapentadol ER in a randomized, double-blind, placebo- and active-controlled phase III study of patients with chronic low back pain

  2009cited by this paper
• Patient barriers to pain management may contribute to poor pain control in rheumatoid arthritis.

  2009cited by this paper
• The role of opioids in managing chronic non-cancer pain.

  2009cited by this paper
• Prevalence of side effects of prolonged low or moderate dose opioid therapy with concomitant benzodiazepine and/or antidepressant therapy in chronic non-cancer pain.

  2009cited by this paper
• Variable Use of Opioid Pharmacotherapy for Chronic Noncancer Pain in Europe: Causes and Consequences

  2009cited by this paper
• The efficacy and tolerability of multiple-dose tapentadol immediate release for the relief of acute pain following orthopedic (bunionectomy) surgery*

  2008cited by this paper
• Single Dose Analgesic Efficacy of Tapentadol in Postsurgical Dental Pain: The Results of a Randomized, Double-Blind, Placebo-Controlled Study

  2008cited by this paper
• Methylnaltrexone for opioid-induced constipation in advanced illness.

  2008cited by this paper
• Methylnaltrexone for opioid-induced constipation in advanced illness.

  2008cited by this paper
• Opioid complications and side effects.

  2008cited by this paper
• What percentage of chronic nonmalignant pain patients exposed to chronic opioid analgesic therapy develop abuse/addiction and/or aberrant drug-related behaviors? A structured evidence-based review.

  2008cited by this paper
• Opioids in the management of chronic non-cancer pain: an update of American Society of the Interventional Pain Physicians' (ASIPP) Guidelines.

  2008cited by this paper
• Patient assessment of a novel therapeutic approach for the treatment of severe, chronic pain

  2008cited by this paper
• Alvimopan, a peripherally acting mu‐opioid receptor (PAM‐OR) antagonist for the treatment of opioid‐induced bowel dysfunction: Results from a randomized, double‐blind, placebo‐controlled, dose‐finding study in subjects taking opioids for chronic non‐cancer pain

  2008cited by this paper
• Review of the treatment options for chronic constipation.

  2007cited by this paper
• (–)-(1R,2R)-3-(3-Dimethylamino-1-ethyl-2-methyl-propyl)-phenol Hydrochloride (Tapentadol HCl): a Novel μ-Opioid Receptor Agonist/Norepinephrine Reuptake Inhibitor with Broad-Spectrum Analgesic Properties

  2007cited by this paper
• System-Related Events and Analgesic Gaps During Postoperative Pain Management with the Fentanyl Iontophoretic Transdermal System and Morphine Intravenous Patient-Controlled Analgesia

  2007cited by this paper
• Opioid-induced bowel dysfunction: prevalence, pathophysiology and burden

  2007cited by this paper
• Absorption, metabolism, and excretion of14C-labeled Tapentadol HCl in healthy male subjects

  2007cited by this paper
• Pharmacologic management of neuropathic pain: Evidence‐based recommendations

  2007cited by this paper
• Opioid dependence and addiction during opioid treatment of chronic pain

  2007cited by this paper
• Efficacy and safety of opioids for osteoarthritis: a meta-analysis of randomized controlled trials.

  2007cited by this paper
• Opioid tolerance and hyperalgesia.

  2007cited by this paper
• Management of Chronic Noncancer Pain in the Primary Care Setting

  2007cited by this paper
• Experiences of patients requiring strong opioid drugs for chronic non-cancer pain: a patient-initiated study.

  2007cited by this paper
• Pain Management: A Fundamental Human Right

  2007cited by this paper
• Survey of select practice behaviors by primary care physicians on the use of opioids for chronic pain

  2006cited by this paper
• Opioids for managing chronic non-malignant pain: safe and effective prescribing.

  2006cited by this paper
• Treatment of chronic moderate-to-severe non-malignant pain with polymer-coated extended-release morphine sulfate capsules

  2006cited by this paper
• Extended-release opioids for the management of chronic non-malignant pain

  2006cited by this paper
• Tapentadol hydrochloride. Analgesic, Mu-opioid receptor agonist, noradrenaline reuptake inhibitor

  2006cited by this paper
• Opioid guidelines in the management of chronic non-cancer pain.

  2006cited by this paper
• Misuse of and dependence on opioids: study of chronic pain patients.

  2006cited by this paper
• Opioids for chronic noncancer pain: a meta-analysis of effectiveness and side effects

  2006cited by this paper
• Opioid therapy for chronic noncancer pain: practice guidelines for initiation and maintenance of therapy.

  2005cited by this paper
• Perception, assessment, treatment, and management of pain in the elderly.

  2005cited by this paper
• The use of opioids in the treatment of osteoarthritis: When, why, and how?

  2005cited by this paper
• Efficacy and safety of opioid agonists in the treatment of neuropathic pain of nonmalignant origin: systematic review and meta-analysis of randomized controlled trials.

  2005cited by this paper
• Management of chronic pain syndromes: issues and interventions.

  2005cited by this paper
• Prevalence of opioid adverse events in chronic non-malignant pain: systematic review of randomised trials of oral opioids

  2005cited by this paper
• Underutilisation of Opioids in Elderly Patients with Chronic Pain

  2005cited by this paper
• Safe use of opioids in chronic noncancer pain.

  2004cited by this paper
• Opioids in chronic non‐cancer pain: systematic review of efficacy and safety

  2004cited by this paper
• Opioids: A review

  2003cited by this paper
• Opioid tolerance and dependence: an inevitable consequence of chronic treatment?

  2003cited by this paper
• Demographics, Assessment and Management of Pain in the Elderly

  2003cited by this paper
• Opioid therapy for chronic pain.

  2003cited by this paper
• Pharmacogenetics of cytochrome P4502D6: genetic background and clinical implication

  2003cited by this paper
• Chronic pain management -can we do better? An interview-based survey in primary care

  2003cited by this paper
• Attitudes toward opioid use for chronic pain: a Canadian physician survey.

  2003cited by this paper
• Management of opioid side effects in cancer-related and chronic noncancer pain: a systematic review.

  2003cited by this paper
• Opioid effectiveness and side effects in chronic pain.

  2003cited by this paper
• The Clinical Opiate Withdrawal Scale (COWS)

  2003cited by this paper
• Use of opioid medications for chronic noncancer pain syndromes in primary care

  2002cited by this paper
• Use of nonopioid analgesics and adjunctive agents in the management of pain in rheumatic diseases.

  2002cited by this paper
• Management of Opioid‐Induced Gastrointestinal Effects in Patients Receiving Palliative Care

  2002cited by this paper
• Chronic opioid therapy for non-cancer pain.

  2001cited by this paper
• Management of opioid-induced constipation

  2001cited by this paper
• Incidence, prevalence, and management of opioid bowel dysfunction.

  2001cited by this paper
• Trends in medical use and abuse of opioid analgesics.

  2000cited by this paper
• Opioids in pain management.

  1999cited by this paper
• Risk-Benefit Assessment of Opioids in Chronic Noncancer Pain

  1999cited by this paper
• Management of chronic pain.

  1999cited by this paper
• Persistent pain and well-being: a World Health Organization Study in Primary Care.

  1998cited by this paper
• mu-Opioid receptor-knockout mice: the role of mu-opioid receptor in gastrointestinal transit.

  1998cited by this paper
• μ-Opioid receptor-knockout mice: the role of μ-opioid receptor in gastrointestinal transit

  1998cited by this paper
• The use of opioids for the treatment of chronic pain. A consensus statement from the American Academy of Pain Medicine and the American Pain Society.

  1998cited by this paper
• Ethical Issues in the Management of Chronic Nonmalignant Pain

  1997cited by this paper
• Pain epidemiology and health related quality of life in chronic non‐malignant pain patients referred to a Danish multidisciplinary pain center

  1997cited by this paper
• Opioid therapy for chronic nonmalignant pain: a review of the critical issues.

  1996cited by this paper
• Opioid Analgesics

  1996cited by this paper
• Assessment and management of pain in the elderly.

  1994cited by this paper
• Two new rating scales for opiate withdrawal.

  1987cited by this paper
• Management of chronic pain.

  1985cited by this paper

• Which type and dosage of mindfulness-based interventions are most effective for chronic pain? A systematic review and network meta-analysis.

  2025cites this paper
• Neurotensin and energy balance

  2023cites this paper
• Medical Cannabis for Chronic Nonmalignant Pain Management

  2023cites this paper
• Acute Pain management in Onco Surgical Patient: Overview

  2021cites this paper
• Antinociceptive Effect of Hinokinin and Kaurenoic Acid Isolated from Aristolochia odoratissima L.

  2020cites this paper
• Correlation between gene polymorphism and opioid efficacy in patients with gastric or intestinal cancer.

  2019cites this paper
• Preliminary Effectiveness of Auricular Point Acupressure on Chemotherapy-Induced Neuropathy: Part 1 Self-Reported Outcomes.

  2019cites this paper
• A prospective randomized controlled study of auricular point acupressure to manage chronic low back pain in older adults: study protocol

  2019cites this paper
• The efficacy and safety of dexamethasone for pain management after total knee arthroplasty: A systematic review and meta-analysis.

  2018cites this paper
• Tapentadol, un nuevo horizonte en el tratamiento de la neuropatía diabética periférica dolorosa

  2018cites this paper
• Assessing and Managing Addiction Risk in Older Adults with Pain

  2018cites this paper
• Constipations as a side effect of opioid anti-pain therapy – current and future treatment methods

  2018cites this paper
• Opioid addiction, diversion, and abuse in chronic and cancer pain

  2018cites this paper
• Comparative pharmacology and toxicology of tramadol and tapentadol

  2018cites this paper
• Responsible, Safe, and Effective Prescription of Opioids for Chronic Non-Cancer Pain: American Society of Interventional Pain Physicians (ASIPP) Guidelines.

  2017cites this paper
• Uloga ljekarnika u liječenju ovisnosti o kodeinu

  2017cites this paper
• Evaluación del dolor con variaciones del videopupilómetro, usando analgesia con tapentadol en Terapia Intensiva Adultos

  2017cites this paper
• Pain intensity and smoking behavior among treatment seeking smokers.

  2016cites this paper
• Analgesic properties of aqueous leaf extract of Haematostaphis barteri: involvement of ATP-sensitive potassium channels, adrenergic, opioidergic, muscarinic, adenosinergic and serotoninergic pathways

  2016cites this paper
• Antinociceptive Effect of 3-(2,3-Dimethoxyphenyl)-1-(5-methylfuran-2-yl)prop-2-en-1-one in Mice Models of Induced Nociception

  2016cites this paper
• Molecular switches of the κ opioid receptor triggered by 6′-GNTI and 5′-GNTI

  2016cites this paper
• Risks associated with drug treatments for kidney stones

  2015cites this paper
• Opioid-induced constipation

  2015cites this paper
• Symptom management in the older adult: 2015 update.

  2015cites this paper
• Successful use of stellate ganglion block and a new centrally acting analgesic with dual mode of action in a resistant temporomandibular joint pain

  2014cites this paper
• EXPLORATION OF SELF-MONITORING AS A THEORY-DRIVEN MANAGEMENT APPROACH FOR CHRONIC PAIN

  2014cites this paper
• Use of Opioids and Sedatives at End-of-Life

  2014cites this paper
• Clinical value of tapentadol extended-release in painful diabetic peripheral neuropathy

  2014cites this paper
• Budget impact analysis of tapentadol extended release for the treatment of moderate to severe chronic noncancer pain.

  2013cites this paper
• Oral Tapentadol as a premedication for the perioperative management of cardiac surgery

  2013cites this paper
• Bowel Function After Tapentadol and Oxycodone Immediate Release (IR) Treatment in Patients With Low Back or Osteoarthritis Pain

  2013cites this paper
• Pharmacological agents currently in clinical trials for disorders in neurogastroenterology.

  2013cites this paper
• Clinical Management of Pain in Advanced Lung Cancer

  2012cites this paper
• Tapentadol extended-release: a recent addition to our analgesic armamentarium.

  2012cites this paper
• NOpiates: Novel Dual Action Neuronal Nitric Oxide Synthase Inhibitors with μ-Opioid Agonist Activity.

  2012cites this paper
• American Society of Interventional Pain Physicians (ASIPP) guidelines for responsible opioid prescribing in chronic non-cancer pain: Part I--evidence assessment.

  2012cites this paper
• Opioid Induced Constipation

  2012cites this paper
• Interdisziplinäre Handlungsempfehlung zum Management von Schmerzen bei älteren Menschen in Pflegeheimen

  2012cites this paper
• American Society of Interventional Pain Physicians (ASIPP) guidelines for responsible opioid prescribing in chronic non-cancer pain: Part 2--guidance.

  2012cites this paper
• Economic Study on the Impact of Side Effects in Patients Taking Oxycodone Controlled-Release for Noncancer Pain

  2012cites this paper
• Can tapentadol cause a false-positive urine drug screen result for amphetamine?

  2012cites this paper
• Deadline Every Second: On Assignment with 12 Associated Press Photojournalists produced by Ken Kobré and John Hewitt. 58 min. Film website: www.deadlineeverysecond.com

  2012influential citation
• Pharmacothérapie de la douleur chronique noncancéreuse chez des patients suivis en première ligne

  2012influential citation
• Constipation - Causes, Diagnosis and Treatment

  2012cites this paper
• Edinburgh Research Explorer Clinical management of pain in advanced lung cancer

  2012cites this paper
• Tapentadol retard en el dolor crónico intenso

  2011cites this paper
• Addictions in pain clinics and pain treatment

  2011cites this paper
• Interval Signet-Ring Cell Adenocarcinoma of the Colon: Missed or De Novo?

  2011cites this paper
• Recent advances in opioid prescription for chronic non-cancer pain

  2011cites this paper
• Acute Abdomen in a Patient with Cancer Pain on Oxycodone

  2011cites this paper
• Breakthrough pain in chronic non-cancer pain: fact, fiction, or abuse.

  2011influential citation
• Effectiveness of long-term opioid therapy for chronic non-cancer pain.

  2011cites this paper
• Tapentadol for multimodal pain management.

  2011cites this paper
• Therapeutic use, abuse, and nonmedical use of opioids: a ten-year perspective.

  2010cites this paper
• Defining clinical issues around tolerance, hyperalgesia, and addiction: a quantitative and qualitative outcome study of long-term opioid dosing in a chronic pain practice.

  2010cites this paper